CD36: The Bridge between Lipids and Tumors
It has been found that the development of some cancers can be attributed to obesity, which is associated with the excessive intake of lipids. Cancer cells undergo metabolic reprogramming, shifting from utilizing glucose to fatty acids (FAs) for energy. CD36, a lipid transporter, is highly expressed...
Main Authors: | Xuan Zhou, Manman Su, Jungu Lu, Deming Li, Xinhui Niu, Yi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/29/2/531 |
Similar Items
-
Intensity of CD36 expression by monocyte subpopulations and blood lipid spectrum parameters in patients without established atherosclerotic cardiovascular disease
by: I. I. Dolgushin, et al.
Published: (2021-08-01) -
Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance
by: Liqun Xia, et al.
Published: (2023-12-01) -
CD36 and Its Role in Regulating the Tumor Microenvironment
by: Xinzhi Liao, et al.
Published: (2022-10-01) -
The polymorphism analysis for CD36 among platelet donors
by: Qilu Lyu, et al.
Published: (2024-04-01) -
CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
by: Noorzaileen Eileena Zaidi, et al.
Published: (2022-11-01)